Your PMOS, Explained.
Reviewed Dr Jo Mackson, MBBS FRACGP
Published May 2026
Reading time About 25 mins, about 3 mins per part
Short on time? Start with the Mini Guide, then come back here when you want the full picture.
As of May 2026, the name PCOS has officially been retired. So if you searched for PCOS and landed here, you are in the right place. The condition formerly known as polycystic ovary syndrome has been renamed polyendocrine metabolic ovarian syndrome, or PMOS, after more than a decade of consensus work led by Australian endocrinologist Professor Helena Teede at Monash University. The change was published in The Lancet in May 2026 and is being rolled out across clinical guidelines, medical education, and international disease classifications over the next three years.
We use the new name throughout this guide, with PCOS in brackets where it helps. If you have been told you have PCOS, you have PMOS. Nothing about your diagnosis, your treatment, or your body has changed. The name has just caught up with the science.
Before we begin our deep dive into PMOS, we need to acknowledge why you are reading this in the first place.
Women’s health, and women’s hormonal health in particular, has been under-researched, over-simplified and too often dismissed, leaving many of us trying to make sense of our own bodies without the education we need to do so.
That is why this Deep Dive exists.
Because as women, most of us were never taught the specific biology that shapes so much of our lives. School sex ed for many of us was a brief tour of the fallopian tubes, an introduction to pads and tampons, and the unforgettable awkwardness of a condom on a banana. It probably did not cover ovulation properly. It almost certainly did not cover insulin resistance, androgen excess, irregular cycles, acne, weight stigma, or why a condition like PMOS can affect everything from periods to skin and from fertility to long-term metabolic health.
Our mothers, aunties and grandmothers were often taught even less. So the knowledge gap has been quietly handed down for generations.
This stops here.
So bear with us if this Deep Dive gets a bit science-heavy, and we apologise in advance for any flashbacks to the Year 8 science lab. We promise it will be worth it, because we believe understanding the biology behind PMOS is far more useful than knowing how plants turn sunlight into food. Unless you are a botanist.
Because once you understand the why, everything that follows, the symptoms, the investigations, the treatment options, starts to make sense.
So yes, there will be medical terminology, the odd graph, and drug names that look like a toddler was let loose on a keyboard. Read it at your own pace. Skip ahead if you need. Come back to the parts that matter most for you.
Consider this the education that is long overdue. And don’t worry, there is no pop quiz at the end. Although if “androgen excess” comes up at your next trivia night, you can thank us later.
Now, before we let you loose below, a quick note about that medical terminology. If you are reading online, just toggle your mouse over and you can get a brief definition. If you have printed and are reading it old school, hats off to you. We have included a glossary at the end of the guide just for you.
What PMOS Actually Is.
What PMOS actually is.
Polyendocrine metabolic ovarian syndrome, or PMOS, is one of the most common hormonal conditions affecting women of reproductive age. It affects around 1 in 8 women worldwide, and probably more, because studies suggest up to 70% of women who have it have never been diagnosed.
Until May 2026, this same condition was called polycystic ovary syndrome, or PCOS. It was, for decades, one of the most badly named and worst explained conditions in women’s health. The rename to PMOS, after more than a decade of work led by Australian endocrinologist Professor Helena Teede at Monash University, is a long-overdue correction. The new name finally describes what the condition actually is: poly-endocrine (multi-hormone), metabolic (insulin-driven), and ovarian (where it shows up, even if not where it starts).
If you have been diagnosed with PCOS or, more recently, PMOS, the explanation you got was probably short, the things you have read since have probably contradicted each other, and you have probably been left more worried than you need to be. This guide is here to change that.
The new name does most of the work of telling you what PMOS actually is. Poly-endocrine means it involves many hormones, not just one. Metabolic means it starts in the way your body handles a hormone called insulin. Ovarian means the ovaries are where it shows up most clearly, even if they are not where the story begins. So while PMOS involves the ovaries, the ovaries get caught up in something that started somewhere else: with how your body handles insulin.
So, what is insulin, and why does it cause such havoc?
Insulin is a hormone your body uses to get energy out of the food you eat. When you eat a carbohydrate, Vegemite toast, an apple, or a sneaky Tim Tam, your body breaks it down into glucose, which is the fuel your body and brain run on. To get from your stomach to your brain, glucose first gets absorbed into your bloodstream. But your blood vessels can only handle so much glucose for a certain period of time. Too much for too long causes damage. So your body needs to clear it out of your bloodstream and into your cells fast. Enter insulin.
Think of insulin as a key. When your blood sugar rises after eating, insulin travels through your body and unlocks your cells, letting the sugar move out of your blood and into them, where it is either used for energy straight away or stored for later.
In insulin resistance, like in PMOS, the locks get stiffer. The key still fits, but it sticks, and it takes a few more turns to open the door. So the sugar lingers in the blood for longer, and the pancreas, noticing it hanging around, responds by sending more insulin. At this point, we need to retire the lock and key, because the complexity of the human body refuses to fit a single tidy analogy. So let’s think about insulin instead as a cup of coffee. For a healthy person, a skim latte in the morning is enough to get going for the day. But if you’d had a late night, or you’re running on empty in the middle of a big project, one cup isn’t going to cut it. You might need two, three, even four double espressos to get the same lift. Let’s call these people insulin resistant. And just like the extra coffee, you do eventually get the effect you were after. Coffee gets you your energy; insulin gets your blood sugar into the cells.
But all that extra caffeine racing through your system can do more than just wake you up. You might get the shakes, a headache, a racing heart. In the same way, excessively high insulin levels don’t quietly work on glucose alone. They have knock-on effects elsewhere in the body, in the liver, the brain, and the ovaries.
| Where it lands | What high insulin does there |
|---|---|
| Your brain | High insulin disrupts the brain signals (LH and FSH) that coordinates ovulation and your monthly period. Because of these disrupted signals, the follicles that hold your eggs in your ovaries may begin to develop as normal but they then stall partway. This can cause ovulation to occur later than it’s meant to or even stop altogether. Cue longer cycles and irregular periods. Over time those stalled follicles also build up in the ovary. On an ultrasound, those follicles look like little cysts (even though they are not), and that is what gets described as ‘polycystic’ ovaries. |
| Your liver | High insulin also causes the liver to produce lower amounts of a protein called SHBG (sex hormone binding globulin). SHBG normally keeps testosterone bound and inactive. So with less SHBG, more of a woman’s natural testosterone is circulating freely, where it can have a bigger impact than normal on skin, hair, and fat tissue. |
| Your ovaries | To make the androgen picture worse, these high insulin levels also drive the ovaries to produce more testosterone than they would normally make. Combined with the lower SHBG from the liver, the result is even more free, active testosterone in the body, causing worse skin, hair, weight and mood changes. |
| Your weight | High insulin also makes it easier to put on weight, especially around the middle. And what’s worse, it makes that weight harder to lose too. The metabolic effects of PMOS feed into the way the body stores and uses fat, which is part of why weight management in PMOS is so important. |
And there is one more layer that often gets missed. Mental Health. Women with PMOS have higher rates of anxiety, depression, and disordered eating than women without it. Some of that is biological: insulin and androgens both affect mood directly. Some of it is the lived experience: managing a condition that affects your skin, your hair, your weight, your cycle, and sometimes your fertility, in a world that has a lot of opinions about all of those things, is really hard. Some of it is the years of being misdiagnosed, dismissed, or told to “just lose weight” before anyone took the time to explain what was actually going on. All of it is real. And all of it deserves to be part of the conversation when we talk about PMOS, not an afterthought at the end of an appointment.
That is the true picture of PMOS. A full-body, complex condition that is far more than just your ovaries. It is not just about periods. And it is not just about weight, no matter what you may have been told.
PMOS is a metabolic condition with reproductive side effects, not a reproductive condition with metabolic complications. The new name finally says it out loud.
You don’t catch PMOS. And it is not your fault.
PMOS is a complex condition. There is no simple “A causes B” explanation. It comes from the way your genes, your body, and your environment all interact with each other. It tends to run in families, so if your mum, sister, or aunt has it, you are more likely to have it too. But genes are not the whole story. PMOS might be in your biology, but how it actually shows up, and how much it affects your day-to-day life, is not set in stone.
How PMOS shows up in your body can change with things like nutrition, movement, sleep, stress, weight, and even age. That is the important part: while PMOS might not be your fault, that doesn’t mean how it shows up is out of your hands.
That is why we are going to take the time to explain it properly. Because once you understand what is actually driving PMOS, the symptoms start to make sense. The tests your doctor orders start to make sense. So do the treatments, and the reasons why some work better than others and why lifestyle management is key to all of it.
Why the rename, and what it changes for you.
If you have been diagnosed with PCOS at any point over the past few decades, you will know the name caused more confusion than clarity. So it is worth a brief tour of where the old name came from, why it was wrong, and why the new one is better.
The original name dates back to the 1930s, when two American gynaecologists identified the condition by examining the ovaries of women presenting with irregular periods, infertility, and excess hair growth. They saw what looked like small bubbles on the ovaries, called them cysts, and the name stuck, simple as that. The science has moved on since then. The hormonal mechanism is now well-understood. The metabolic origin is now well-understood. The name however, until 2026, stayed. The issue being the PCOS name was falsely giving women the impression that cysts on their ovaries were causing all the chaos. When actually there are no cysts, and the ovaries are a bystander not the instigator.
A real cyst is a fluid-filled sac. What an ultrasound actually shows in PMOS is a collection of small, immature follicles, each containing an egg that hasn’t been ovulated. Why does this happen?
In a normal cycle, a group of follicles starts growing each month, but due to hormone signalling from the brain, only one becomes dominant, and goes on to release its egg at ovulation. In PMOS, because of the disrupted hormonal signals we walked through above, the brain never sends the signal that selects a dominant follicle. Without that signal, none of the follicles progresses to maturity. They all stall partway, no egg is released, and instead they stay in the ovary, giving the appearance of multiple little cysts. They are not painful. They are not harmful in themselves. And they are a consequence of irregular ovulation, not the cause of it.
It’s also important to know that many women, especially younger women and those with high AMH, have ovaries that can look polycystic on ultrasound but do not have PMOS. Polycystic ovaries on an ultrasound is a finding, it is not a diagnosis. Under the old name, the syndrome and the ultrasound finding shared a word, which caused real confusion. The rename helps clear this up.
The new name, polyendocrine metabolic ovarian syndrome, does two things the old one did not.
1. The change from Polycystic to Polyendocrine shifts the focus from "many cysts" to "many hormones," which is exactly where the focus belongs. PMOS involves disruption across multiple hormones, including LH, FSH, oestrogen, progesterone, testosterone, and insulin, not just a structural problem in the ovaries.
2. The change from C to M puts metabolic front and centre where it belongs. The old name implied a purely structural condition. The new name names the central cause: insulin resistance, and the knock-on metabolic effects that follow. This is the part of PMOS that does most of the work behind the symptoms, and the part that responds most powerfully to good management.
This name change will not fix decades of confusion overnight, but it will, over time, help women arrive at their diagnosis with a clearer understanding of what they actually have.
The single biggest worry most women bring to a PMOS diagnosis is fertility. If that is what you are reading this guide to find out about, jump ahead to Part Seven, where we walk through what PMOS actually means for having children. The short version: most women with PMOS who want children, do. The longer version is in Part Seven, and worth the wait.
How PMOS Is Diagnosed.
How PMOS is diagnosed.
Women usually arrive at a PMOS diagnosis through one of a handful of doorways. For some it is irregular or absent periods. For others it is persistent acne, excess facial or body hair, or thinning on the scalp that nothing over the counter seems to fix. For others again it is weight that has crept up despite no obvious change in habits. For some, the first sign is difficulty conceiving. The symptom mix is wide, which is part of why PMOS can take years to diagnose, and part of why we want to walk through how a careful workup actually happens.
PMOS (formerly PCOS) is a clinical diagnosis. There is no single test that tells a woman she has it. Instead working out whether it is PMOS involves three things: listening to your symptom story, ruling out other conditions that can look like PMOS, and gathering the evidence that supports the diagnosis. Only once those three pieces line up can a doctor say with confidence that this is PMOS, and not something else.
Several conditions can cause the same symptoms as PMOS: irregular periods, acne, excess hair, weight changes, and fatigue. Ruling them out is a non-negotiable step in the diagnostic process. We walk through the main look-alikes in Part Three.
| The look-alike | Why we check, and how |
|---|---|
| Thyroid dysfunction | Both an underactive and overactive thyroid can cause cycle irregularity, mood changes, weight changes, fatigue, and skin changes, symptoms that overlap almost perfectly with PMOS. Thyroid disease is more common in women, and can coexist with PMOS. A standard thyroid panel (TSH +/- a free T4) is part of any initial PMOS workup. |
| Hyperprolactinaemia | Prolactin is the hormone responsible for breast milk production. In women who are not pregnant or breastfeeding, elevated prolactin can disrupt the hormonal signals needed for ovulation, causing irregular or absent periods. It can be caused by certain medications, by thyroid problems, or by a small benign tumour on the pituitary gland called a prolactinoma. It’s a straightforward blood test, and an important one to check. |
| Premature ovarian insufficiency (POI) | In women with very infrequent or absent periods, it is important to confirm the ovaries are still functioning and have not entered early menopause. FSH helps make that distinction. POI has very different implications for fertility, bone health, and long-term management, which is why identifying it early matters. |
| Functional Hypothalamic Amenorrhoea (FHA) | FHA is another situation where women can have very infrequent or absent periods. It happens when the brain dials down the hormonal signals that drive the menstrual cycle, usually because the body is under significant stress from; not enough food, too much exercise, rapid weight loss, or prolonged emotional stress. From the outside it can look a lot like PMOS. But the underlying picture is the opposite. A blood test tells us which one we are dealing with, and the distinction matters, because treating FHA as though it were PMOS can sometime make things worse, and misses the important priority is restoring energy balance, not regulating the cycle with the pill. FHA and PMOS can also coexist, which is why a thorough assessment is always worthwhile. |
| Non-classic congenital adrenal hyperplasia (NCAH) | A rare genetic condition in which the adrenal glands produce excess androgens. It can look almost identical to PMOS, with irregular cycles, acne, and excess hair growth. We screen for it with a morning blood test for 17-hydroxyprogesterone. Even though it’s rare, catching it is important as it too is managed differently. |
| Androgen-secreting tumour | Very rare, and worth mentioning only so it can be put in context. If androgen levels on blood tests are very significantly elevated, well above the range seen in PMOS, or if symptoms appeared suddenly and have progressed rapidly, we need to investigate further. |
| Pregnancy | Nature’s most reliable plot twist. Irregular cycles make a missed period easy to overlook, and PMOS has a well-documented sense of humour: unpredictable ovulation plus the assumption that conception will be difficult is a combination that catches people off guard more often than you would think. |
The exact panel of tests depends on your story, but a thorough workup usually covers androgens (testosterone and free androgen index, with DHEAS if those come back normal), your metabolic baseline (fasting glucose, insulin, lipids, and liver function), and a rule-out screen (thyroid function, prolactin, and others depending on symptoms). Your doctor will not necessarily order all of these in one go. The point is not to tick a list, but to build the picture.
Once the look-alikes have been ruled out and the investigations are in, the formal framework doctors use to confirm a diagnosis is called the Rotterdam Criteria. A woman is diagnosed with PMOS when at least two of the following three features are present.
1. Irregular or absent ovulation. Either cycles consistently longer than 35 days or fewer than 8 cycles a year, or absent periods altogether. If you are currently on hormonal contraception, you will have withdrawal bleeds regardless of what your underlying cycle is doing, so this criterion can only be properly assessed when you are cycling naturally.
2. Signs of androgen excess. Either visible signs on the body (acne, excess facial or body hair, or hair thinning on the scalp) or elevated androgen levels on blood tests. The first-line tests are total testosterone and free androgen index. If these come back normal, DHEAS may be checked as a second-line test. The visible signs alone are enough, and blood tests can come back normal in some women with PMOS.
3. Polycystic ovarian morphology on imaging or AMH. If a woman has 20 or more small follicles on one or both ovaries on ultrasound, or ovarian volume greater than 10mL, that is considered polycystic ovarian morphology. As a newer alternative, an AMH level above a defined threshold (which varies with a woman’s age) can now be used in place of the ultrasound finding. But remember: having polycystic ovaries on ultrasound or a high AMH does not mean you have PMOS.
Not All PMOS Looks the Same: The Four Phenotypes.
Four versions of the same condition.
Because the Rotterdam Criteria require only two of the three features, and because lifestyle factors can express how intensely symptoms present, PMOS can look very different from one woman to the next. There are four recognised phenotypes, four distinct presentations of the same underlying condition, and understanding which one applies to you shapes both what you experience and how it is managed. The ‘polyendocrine’ part of the new name helps explain why the phenotypes vary so much.
| Phenotype | What it looks like, and what it means |
|---|---|
| Phenotype A (Classic), ~60% | Irregular periods + signs of androgen excess (acne, excess hair, hair thinning) + follicles on ultrasound or elevated AMH. The triple whammy. Phenotype A is most common presentation, and usually the most noticeable. Women are most likely to have significant cycle irregularity and visible androgenic symptoms. They also carry the highest long-term metabolic risk, meaning a greater chance of developing type 2 diabetes and cardiovascular disease over time. |
| Phenotype B (Classic), ~15% | Irregular periods + signs of androgen excess, without the ultrasound or AMH finding. Clinically very similar to Phenotype A in terms of symptoms and management, with the same metabolic risk profile. But often missed or dismissed because of normal ovaries on ultrasound. Hopefully with the new PMOS name change there will be less women missed with Phenotype B. |
| Phenotype C (Ovulatory), ~20% | Signs of androgen excess + follicles on ultrasound or elevated AMH, with regular cycles. Sometimes called the ‘hidden’ phenotype, because regular cycles often mean it goes unnoticed for longer. Women are sometimes diagnosed when investigating acne or excess hair, or during an ultrasound for another reason. |
| Phenotype D (Non-androgenic), ~5% | Irregular periods + follicles on ultrasound or elevated AMH, without androgen excess. This is the mildest phenotype in terms of visible symptoms: no acne, no excess hair, no testosterone-related features. Metabolic risk is also lower than Phenotypes A and B, but the fertility picture is similar to other phenotypes. |
Understanding your phenotype gives both you and your doctor a clearer map: the symptoms to expect, the risks to monitor, and the treatments most likely to help.
The Five Pillars of PMOS Management.
The five pillars of good PMOS care.
PMOS is a lifelong condition. There is no cure, but with the right approach, symptoms can be well controlled and long-term risks substantially reduced. We think about PMOS management in terms of five core areas. Addressing all five is what good PMOS care looks like.
Women with PMOS have a higher lifetime risk of developing type 2 diabetes, dyslipidaemia (abnormal cholesterol and triglyceride levels), high blood pressure, and cardiovascular disease. These are risks, not certainties, and that risk can be reduced substantially through lifestyle, monitoring, and medication. In a frustrating “quirk” of biology, excess weight and insulin resistance feed each other and create a vicious cycle: excess weight worsens insulin resistance, which makes PMOS symptoms worse, which makes weight management harder. Breaking that cycle, even partially, is where the biggest risk benefits come from.
Lifestyle management is the most powerful tool we have, and is covered in detail in Part Six. Medications including metformin and inositol supplements also have a role, and we cover those in Part Seven.
In PMOS, infrequent or absent ovulation means the lining can build up without being reliably shed. Over time, this can lead to endometrial hyperplasia (an abnormally thickened lining) and, if untreated over a long period, an increased risk of endometrial cancer.
This sounds scarier than it is. The 2023 International PCOS Guideline puts it plainly: the risk of endometrial cancer in PMOS is real but absolute risks remain low. The way we manage it is straightforward: women with PMOS who are not on hormonal treatment should aim for a bleed at least every three to four months. If your periods are less frequent than that, a hormonal option to protect the lining is recommended, whether that is the combined pill, cyclical progesterone, or the Mirena IUD. If your periods are very infrequent and you are not on any hormonal treatment, this is worth raising with your doctor or coming in for a proactive chat with us.
Excess androgens drive the most visible and often most distressing symptoms of PMOS: acne, hirsutism (excess facial and body hair), hair thinning on the scalp, and oily skin. The approach ranges from hormonal to topical to procedural, and while it may seem like just aesthetics, androgen management also impacts weight and mood and addressing it is a central part of complete PMOS care.
As we talked about earlier, PMOS is associated with higher rates of anxiety, depression, disordered eating, and body image distress. This is partly biological (androgens and insulin resistance both affect mood) and partly the lived experience (managing a chronic condition that affects your appearance, your weight, and sometimes your fertility takes a toll). Rates of anxiety and depression in women with PMOS are around two to three times higher than in the general population. The social media landscape around PMOS can also be overwhelming, full of conflicting and commercially motivated information, and many women arrive at appointments already anxious and confused. Mental health belongs at the centre of PMOS care, not at the end of the appointment.
Fertility is an important consideration in PMOS, but only for some women, and it is shaped by personal circumstance and choice. For those for whom it matters, the good news is that the fertility challenges associated with PMOS are among the most treatable in reproductive medicine. Good lifestyle management alone can restore regular ovulation. When it does not, there are well-established and effective options. The full picture is in Part Eight.
Lifestyle: The Most Powerful Tool We Have.
Why lifestyle comes first.
Lifestyle is where every PMOS conversation needs to start, and we say that knowing full well it is not what most people want to hear. We wish there was a once-daily capsule containing a Mediterranean diet, 2 resistance sessions, 3 spin classes, eight hours of sleep, and a manageable stress load. Sadly, that is not the world we live in, at least not yet. So we have to do the heavy lifting ourselves, pun intended. What we can offer instead is the understanding of why it works. Because when you know that a low-GI dinner or an extra resistance session is directly reducing the testosterone driving your symptoms, it starts to feel less like a chore and more like an informed choice.
The dietary approach with the strongest research behind it for PMOS is a balanced Mediterranean-style diet with a focus on carbohydrates with low glycaemic index (low GI). Here is why it works. When you eat foods that release glucose quickly (High GI foods - sugary foods or white bread/rice/pasta), insulin has to be secreted quickly and in high amounts to match. In a system already prone to insulin resistance, insulin can then spike even higher and drive androgen production up even more. Low GI eating, choosing whole grains over refined ones, building meals around protein and healthy fats, limiting added sugar, reduces those spikes, and in doing so reduces the symptoms caused by high androgens.
The Mediterranean dietary pattern also has good evidence in PMOS for improving metabolic markers and supporting mood. Working with a dietitian who understands PMOS can make a significant difference, not only in what to eat, but in building an approach that is flexible, sustainable, and realistic for your life.
Good PMOS nutrition is not about eating less or eating perfectly. It is about eating in a way that keeps your insulin steady, and building a sustainable approach with a respect for food, beyond good and bad.
Social media is full of PMOS diet and supplement advice: elimination diets, gluten-free protocols, seed cycling, hormone balancing supplements. The evidence for most of these claims is weak and the promises overstated. The actual advice, once you cut through the noise, is pretty simple: eat well and keep your blood sugar steady. There is no list of foods you must never eat again, no perfect macro split to hit, no mysterious trigger foods to eliminate. Changing the way you eat is already a big ask. Adding guilt, restriction, and rules with no evidence makes it considerably harder, and mostly likely no more effective.
Women with PMOS are at higher risk of disordered eating, and nutritional advice that centres on weight loss, ‘bad foods,’ or strict rules can sometimes do more harm than good. Weight is not the only metric that matters in PMOS, and for women already struggling with their relationship with food, a weight-focused approach can become a barrier to getting help. The goal of nutritional management in PMOS is metabolic health, not a number on the scales. PMOS care should take into account the emotional complexity of weight, not just its metabolic significance. If this is something you find difficult, you are not alone, and it is worth saying so. This is something we take seriously, and something we will always make space for.
Both aerobic exercise (anything that raises your heart rate: brisk walking, swimming, cycling, dancing) and resistance training (weights, resistance bands, Pilates, or bodyweight exercises) have independent and complementary benefits in PMOS. Aerobic exercise improves how your cardiovascular system and cells respond to insulin. Resistance training builds muscle, which is metabolically active tissue that takes up glucose from the bloodstream, reducing the demand on insulin and improving insulin sensitivity over time.
Around 150 minutes of moderate exercise per week has good evidence for improving cycle regularity, reducing androgen levels, and supporting mood in PMOS. But that is the general recommendation for all women, not a PMOS-specific target, and movement does not only count when you hit a weekly number. Every session counts. Every step has a benefit. Every rep is shifting your hormonal environment in the right direction. Start small, stay consistent, and watch the habit build itself. Movement in PMOS is less about perfection and hitting a weekly target, and more about using movement as self-care, knowing that every time you do, your insulin sensitivity, your energy, and your mood are all quietly improving.
For women where weight is contributing to insulin resistance, a 5 to 10% reduction in body weight can be enough to restore ovulation, reduce androgen levels, and improve metabolic markers, without needing to reach any particular BMI target.
It is equally important to say: PMOS exists across all body weights, and lean women with PMOS can have significant insulin resistance too. Framing PMOS care primarily as weight management is inaccurate and, for women who have already struggled with their weight, can make it harder to seek help. Metabolic health is the goal. Weight may or may not be part of how we get there.
For women where lifestyle changes alone are not achieving the metabolic results needed, GLP-1 receptor agonists (such as semaglutide, used in Wegovy and Mounjaro) are an emerging option in PMOS management, particularly where weight and insulin resistance are significant contributors. This is a conversation worth having with your doctor if it applies to you.
Sleep disturbance is more common in women with PMOS and, in a particularly unhelpful twist of biology, is itself a driver of insulin resistance and weight gain. Sleep-disordered breathing, including obstructive sleep apnoea, is also significantly more prevalent in PMOS than in the general population. Prioritising sleep quality, investigating any underlying sleep disorders, and maintaining consistent sleep-wake patterns all support better hormonal and metabolic outcomes.
Chronic stress elevates cortisol, which directly worsens insulin resistance and can further disrupt the hormonal environment of PMOS. Stress management is a clinically relevant component of PMOS care, not an optional extra. Mindfulness-based interventions have specific evidence in PMOS for reducing perceived stress and improving quality of life. Prioritising rest and recovery in PMOS is not self-indulgent. It is part of the treatment.
Treatment Options.
The PMOS toolkit.
While the five pillars of management apply to every woman with PMOS, the specific treatments that sit within them are always individualised. Phenotype, symptoms, contraceptive needs, fertility goals, life stage, and metabolic profile all shape what makes sense. What works well for one woman may not suit another. Below are the most commonly used options in our PMOS toolkit.
| Option | What it does, and who it suits |
|---|---|
| The Combined Oral Contraceptive Pill (COCP)aka. “The Pill” | The most widely used hormonal treatment in PMOS is the COCP. It provides cycle regulation, endometrial protection, and some degree of androgen suppression. Some pills are more beneficial than others for PMOS, but any COCP can be a reasonable starting point depending on individual history and preferences. |
| Body-Identical Oestrogen COCPsQlaira (oestradiol valerate + dienogest). Zoely (17β-oestradiol + nomegestrol acetate). Nextstellis (estetrol + drospirenone). | Body-identical oestrogen pills are a good option for women who have had side effects on other synthetic pills. They are also particularly useful for acne and hirsutism, thanks to their antiandrogenic progestogens.Worth knowingOf the three, Nextstellis is the only one currently PBS-listed. While Qlaira and Zoely remain excellent options, cost may need to be a practical consideration. |
| Yasmin / YazEthinylestradiol + drospirenone. Yasmin: 30mcg EE. Yaz: 20mcg EE. | Women with PMOS and significant androgenic symptoms, acne, or fluid retention. Both are PBS-listed. Yasmin (30mcg EE) is generally preferred for PMOS, and in women under 25 where the higher oestrogen dose also supports bone mineral density. Yaz (20mcg EE) is still a good option and may suit women who are sensitive to oestrogen.Worth knowingYasmin’s higher oestrogen dose generally provides slightly stronger androgen suppression, but both are good options. The choice often comes down to oestrogen tolerance and individual side-effect profile. Both should be reviewed regularly, particularly if cardiovascular risk factors change over time. |
| SlindaDrospirenone 4mg, progestogen-only. | Women who cannot use oestrogen-containing contraception (due to migraine with aura, VTE history, cardiovascular risk factors, breastfeeding) but still want some antiandrogenic benefit from their contraception.Worth knowingSlinda does not provide the same androgen suppression or endometrial protection as a COCP, so in women with significant anovulation, it might not be the best option. |
| Mirena IUDLevonorgestrel, locally delivered. | Women who need endometrial protection but cannot or prefer not to use systemic oestrogen. Also provides highly effective long-term contraception.Worth knowingProtects the uterine lining effectively, and most women stop having periods over time. Because the hormone is delivered locally with minimal systemic absorption, it does not address androgenic symptoms, but it can be combined with other treatments for acne, excess hair, or systemic symptoms. |
| MetforminOral insulin sensitiser. | Best known as a diabetes medication, but used safely and effectively in PMOS in women without diabetes. It works by improving the body’s sensitivity to insulin, which in turn helps reduce androgen levels and can improve cycle regularity. A useful option for women with confirmed or borderline insulin resistance, metabolic syndrome, or those preparing for pregnancy where it can support cycle regulation.Worth knowingHas meaningful effects on cycle regularity and androgen levels. GI side effects are common initially. Starting low and increasing gradually reduces this. Extended-release formulations are generally better tolerated. |
| SpironolactoneOff-label antiandrogenic medication. | Spironolactone is a medication primarily used for fluid retention and blood pressure, but in women with PMOS it is used off-label for its antiandrogenic properties. It works by blocking the effect of testosterone on the skin and hair follicles. A good option for women with significant hirsutism, acne, or scalp hair loss who cannot use or do not want the COCP, or it can be taken alongside the COCP if androgenic symptoms are not fully controlled.Worth knowingEffective at 50 to 200mg daily, but takes 3 to 6 months to see the full effect. Requires reliable contraception, as it is teratogenic in pregnancy. |
| InositolMyo-inositol + D-chiro-inositol (40:1 ratio), supplement. | Inositol is a naturally occurring compound involved in insulin signalling. A good option for women who want a non-pharmaceutical addition to their PMOS management, or as a supplement to other treatments. Particularly used in preconception support, and for women who cannot tolerate metformin.Worth knowingNot a replacement for lifestyle or medical treatment in significant PMOS, but a well-evidenced and generally well-tolerated option. |
Using the COCP to manage PMOS does not affect your future fertility. This is one of the most common and understandable concerns we hear, but the evidence is clear. The pill suppresses ovulation while you take it, and ovulation returns to its usual pattern (including its PMOS pattern) after stopping. The pill does not change your ovarian reserve, deplete your follicle pool, or cause your PMOS to worsen. On the ‘masking’ concern: it is true that the pill manages PMOS symptoms rather than treating the underlying cause. But managing symptoms effectively is the goal of most chronic disease management, and the pill does it well. When the pill is stopped, the underlying PMOS will return as expected, but it will not have been made worse. Some women experience a delay in cycle return after stopping the COCP. This is not permanent and not a sign of damage. It is simply the ovaries re-establishing their pattern. It is not predictable who will experience this, which is why it is useful to be aware of, not a reason to avoid the pill. Fertility after stopping the pill in PMOS depends on the same factors it always would have: ovulation frequency, age, partner fertility, and any other contributing factors.
PMOS and Fertility: What the Evidence Actually Shows.
What PMOS really means for having children.
This is usually the first section women want to read after a PMOS (formerly PCOS) diagnosis, which is why we have put it last. By the time you reach this page, you have the context to understand it properly. A PMOS diagnosis can feel, particularly after a brief clinical explanation followed by a deep dive into scaremongering social media, as though the door to having children has been quietly closed. It has not. Whatever the algorithm may have served you, the evidence is not all doom and gloom.
Most women with PMOS who want to have children, do. The fertility challenges associated with PMOS are among the most treatable in reproductive medicine.
PMOS is the most common cause of anovulatory infertility, which is infertility caused by infrequent or absent ovulation. But anovulatory infertility is also one of the most treatable forms. The word ‘infertility’ here does not mean permanent inability to conceive. In practice, it means two things: ovulation may not be happening reliably, and even when it is, the unpredictability makes timing conception very difficult. The good news is that ovulation in PMOS can almost always be supported, restored, or at the very least tracked well enough to work with.
There is an important distinction between women who are diagnosed with PMOS during a fertility investigation (where conception has already been difficult) and women who are diagnosed earlier, during a workup for irregular periods, acne, or a routine health check. These are different situations. One of the strongest arguments for early diagnosis and good PMOS education is this: if you understand that your cycles are unpredictable and you know how to track them properly, you can time conception attempts accurately. If you do not know you have PMOS, you may have been trying at the wrong time in an unpredictable cycle for months without realising it. Knowledge makes a practical difference.
Because PMOS causes cycles that vary significantly in length, ovulation does not fall on a predictable day. The standard assumption that ovulation happens on ‘day 14’ simply does not apply. For women with PMOS trying to conceive, cycle tracking is a valuable first step.
Standard period-tracking apps, which predict fertile windows based on assumed cycle regularity, are not reliable for PMOS. Apps where you manually enter actual data, including basal body temperature (BBT), ovulation predictor kit (OPK) results, and symptoms, give a much more accurate picture. On the topic of OPKs: in PMOS, LH (the hormone OPKs typically measure) can surge unpredictably, and LH-only strips can give misleading readings. Dual-hormone OPKs, which measure both LH and oestrogen together, are more reliable for tracking ovulation in PMOS.
If cycles are very long or very irregular, a conversation with your doctor about monitored ovulation tracking (using ultrasound and blood tests to confirm when or whether ovulation is occurring) is a practical next step before considering referral to a fertility specialist.
If ovulation is not occurring regularly, or if well-timed conception attempts have not resulted in pregnancy after a reasonable period (typically 6 months of trying, though this depends on age and other factors), the next step is ovulation induction. This is not jumping to IVF. It is a well-established, stepwise process.
Step 1: Induce a period. A short course of progesterone can bring on a period and start a new cycle that can be properly timed from day 1.
Step 2: Stimulate ovulation. Oral medications like Letrozole or Clomiphene (Clomid) can drive follicle development and trigger ovulation, so that intercourse can be timed accurately.
Step 3: If needed, injectable options are available for women who have not responded to oral medication.
IVF is not the default option for PMOS, and most women with PMOS who are trying to conceive will not need it, particularly if PMOS is the only factor. It becomes relevant when simpler approaches have not succeeded, or when there are additional contributing factors such as male factor infertility, fallopian tube issues, endometriosis, or age-related considerations.
When IVF is needed, women with PMOS tend to respond well to stimulation because of their larger follicle pool and higher AMH. More eggs retrieved means more opportunities to create viable embryos. In reproductive medicine, it is a bit of a numbers game, so this matters.
Good PMOS management before pregnancy matters not only for fertility, but for the pregnancy itself. Women with well-managed PMOS and good metabolic health have better pregnancy outcomes. Women with PMOS do carry a higher risk of gestational diabetes, gestational hypertension, and preterm birth during pregnancy, but these risks are substantially reduced with good preconception care. If you are planning to conceive in the next year, a preconception consultation 3 to 6 months ahead is strongly recommended.
Your PMOS Check-In: What to Monitor, and When.
Keeping an eye on the long game.
Because PMOS has long-term implications beyond the reproductive years, ongoing monitoring is an important part of living well with it. The table below is a practical guide. Your doctor may adapt the frequency based on your individual situation, and if you are not up to date with any of these, consider this your sign to book in.
| What we check | When, and why |
|---|---|
| Fasting glucose, HbA1c, and OGTT | Fasting glucose and HbA1c annually. 75g OGTT at diagnosis, and every 1 to 3 years thereafter. PMOS significantly raises the risk of progressing to prediabetes and type 2 diabetes. The OGTT (a 2-hour glucose tolerance test) picks up impaired glucose tolerance that fasting glucose alone can miss. |
| Fasting lipids | Annually. PMOS is associated with elevated triglycerides and reduced HDL cholesterol, a pattern that raises cardiovascular risk over time. A full lipid panel gives us the complete picture. |
| Blood pressure | At each visit. Elevated blood pressure risk is well-established in PMOS. Tracking trends over time is more useful than any single reading. |
| Weight and waist circumference | At each visit. Both are practical indicators of metabolic risk. Trends matter more than individual measurements, and neither is used as a judgment. They help calibrate the management plan. |
| Androgens (testosterone, FAI, DHEAS) | At diagnosis. Again if symptoms change or treatment is adjusted. Gives us a baseline to compare against and helps confirm whether treatment is having the intended hormonal effect. |
| Thyroid function (TSH) | At diagnosis. Again if symptoms change. Thyroid conditions are more common in women with PMOS, can worsen metabolic and cycle features, and remain an important condition to keep in mind, particularly if symptoms are changing. |
| Vitamin D | At diagnosis. Annually if previously low. Deficiency is surprisingly common, particularly in Australia. Contributes to fatigue, mood, and bone health. Straightforward to identify and correct. |
| Mental health check-in | At each visit. Rates of anxiety and depression are higher in PMOS. A regular check-in keeps this part of the conversation, and ensures you always feel comfortable raising it if things are harder than usual. |
| Endometrial assessment (pelvic ultrasound) | If periods have been absent for 12 months or more without hormonal management. Prolonged absence of periods raises the risk of endometrial hyperplasia. An ultrasound checks the lining thickness, and a biopsy will need to be done if it is thickened. |
| Preconception review | 3 to 6 months before planning to conceive. A dedicated appointment to review and improve metabolic health, review supplements and medications, discuss fertility expectations, and plan any ovulation support that may be needed. |
PMOS Is Just Part of Your Story. Remember, You Are Still the Author.
We understand that a PMOS diagnosis, or for many women an old PCOS diagnosis newly relabelled, can feel overwhelming, and sometimes just unfair. It used to arrive with a misleading name. Thanks to the global rename in May 2026, that part has finally been fixed. But there is still a world of conflicting information online, and the diagnosis is still too often handed over without the clear explanation or practical plan it deserves. We hope this guide has started to change that.
The most important things to take from it. PMOS is a metabolic condition with reproductive side effects, not a reproductive condition with metabolic complications sitting quietly in the background. The new name finally says that out loud, which is no small thing for the generations of women who carried the old one. It is common, heritable, and not your fault. It is lifelong but very manageable. Its symptoms can be well controlled. Its long-term health risks can be substantially reduced. And its implications for fertility, while real, are far more manageable than most women are initially led to believe.
Good PMOS care is individualised, evidence-based, and looks at the whole picture: metabolic health, mental health, reproductive health, contraceptive needs, and quality of life. All of these things matter. All of them are worth addressing. Now that you understand the why, what comes next can be approached with clarity and confidence. And hopefully, a little less Googling at 3am.